GLOW Blend: GHK-Cu, TB-500 and BPC-157 Combined Research Overview

September 28, 2026 · By My Store 3 Admin

The GLOW Blend is a multi-compound research formulation containing three distinct peptide research compounds in a single lyophilised vial: GHK-Cu (copper peptide, 50mg), TB-500 (Thymosin Beta-4 analogue, 10mg), and BPC-157 (pentadecapeptide, 10mg). Each compound has an independent research profile; this article provides a brief overview of each and the rationale for investigating them in combination.

All Bloom Vitality products are supplied strictly for in vitro laboratory and research use only.

Individual Compound Overviews

GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper Complex, 50mg)

GHK-Cu is a naturally occurring tripeptide-copper complex found in human plasma, wound fluid, and tissue. It is the most extensively studied copper-binding peptide in dermal and tissue research. Proposed mechanisms include:

Collagen and extracellular matrix synthesis stimulation in fibroblast cultures
Antioxidant enzyme upregulation (SOD, catalase)
Angiogenesis and pro-healing effects in wound models
Gene expression modulation across multiple repair and remodelling pathways

The 50mg dose in this blend reflects GHK-Cu’s distinctly different dosing requirements compared to the shorter peptide components — it is included at a substantially higher mass to provide research-relevant quantities for in vitro applications. For a full overview, see: What is GHK-Cu? Copper Peptide Research Guide.

TB-500 (Thymosin Beta-4 Analogue, 10mg)

TB-500 is a synthetic analogue of Thymosin Beta-4, a naturally occurring actin-binding protein. Proposed mechanisms include G-actin sequestration (regulating cell migration), anti-inflammatory cytokine modulation, and angiogenesis via VEGF pathways. Preclinical research has focused on tendon, muscle, cardiac, and wound healing models. For a full overview, see: TB-500 (Thymosin Beta-4): Research Overview.

BPC-157 (Body Protection Compound-157, 10mg)

BPC-157 is a 15-amino acid synthetic pentadecapeptide derived from a gastroprotective protein. Proposed mechanisms include VEGFR2 upregulation and angiogenesis promotion, nitric oxide system modulation, and growth hormone receptor interaction. Preclinical research has focused on tendon-to-bone healing, gastrointestinal mucosal repair, and bone healing models. For a full overview, see: What is BPC-157? Research Overview & Mechanism.

Proposed Rationale for Combination

The three compounds in the GLOW Blend operate via distinct but partially overlapping proposed mechanisms:

Compound	Primary proposed mechanism	Strongest preclinical evidence
GHK-Cu	ECM remodelling, copper enzyme activation, antioxidant gene expression	Dermal fibroblast cultures, wound healing
TB-500	Actin regulation, cell migration, NF-κB modulation	Muscle repair, cardiac tissue, wound healing
BPC-157	VEGFR2, nitric oxide, GH receptor	Tendon-to-bone, gastrointestinal, bone

All three compounds share proposed pro-angiogenic and anti-inflammatory properties, approaching these via different molecular mechanisms. Their combination in research protocols is motivated by the hypothesis that the complementary pathways produce effects across a broader range of tissue types and mechanisms than any single compound alone.

Notes on Combined Research

Research protocols using multi-compound blends introduce specific methodological considerations:

Attribution of effects — when multiple compounds are administered simultaneously, it is difficult to attribute observed effects to individual components without adequate controls. Researchers investigating mechanism-specific questions should consider whether single-compound experiments are more appropriate.
Interaction effects — the compounds may produce additive, synergistic, or antagonistic effects depending on the model system. No published data specifically characterises interactions between all three components simultaneously.
Concentration ratios — the fixed ratio in this blend (GHK-Cu 50mg : TB-500 10mg : BPC-157 10mg) reflects the distinct mass requirements of GHK-Cu vs the shorter peptides. Researchers requiring different ratios should consider ordering individual compounds separately.

Research Material

Bloom Vitality supplies the GLOW Blend (GHK-Cu 50mg + TB-500 10mg + BPC-157 10mg) as a lyophilised research formulation, independently third-party tested for purity and potency. All components are part of our broader research peptides UK catalogue. Individual compounds are also available separately: GHK-Cu 100mg, TB-500 10mg, and BPC-157 10mg. Batch-specific Certificates of Analysis are available via our Certificates & Documentation page.